JP2009519915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519915A5 JP2009519915A5 JP2008544833A JP2008544833A JP2009519915A5 JP 2009519915 A5 JP2009519915 A5 JP 2009519915A5 JP 2008544833 A JP2008544833 A JP 2008544833A JP 2008544833 A JP2008544833 A JP 2008544833A JP 2009519915 A5 JP2009519915 A5 JP 2009519915A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- peptide
- amyloid
- disease
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05027091.7 | 2005-12-12 | ||
| EP05027091 | 2005-12-12 | ||
| EP06009098 | 2006-05-02 | ||
| EP06009098.2 | 2006-05-02 | ||
| PCT/EP2006/011861 WO2007068411A2 (en) | 2005-12-12 | 2006-12-08 | Therapeutic vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013025108A Division JP2013126993A (ja) | 2005-12-12 | 2013-02-13 | 治療ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009519915A JP2009519915A (ja) | 2009-05-21 |
| JP2009519915A5 true JP2009519915A5 (cg-RX-API-DMAC7.html) | 2010-01-28 |
| JP5249043B2 JP5249043B2 (ja) | 2013-07-31 |
Family
ID=37836865
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008544833A Active JP5249043B2 (ja) | 2005-12-12 | 2006-12-08 | 治療ワクチン |
| JP2013025108A Withdrawn JP2013126993A (ja) | 2005-12-12 | 2013-02-13 | 治療ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013025108A Withdrawn JP2013126993A (ja) | 2005-12-12 | 2013-02-13 | 治療ワクチン |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7807175B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2380588B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5249043B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101152557B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101330923B (cg-RX-API-DMAC7.html) |
| AR (1) | AR058327A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006326283B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0619747B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2633399C (cg-RX-API-DMAC7.html) |
| CR (1) | CR9994A (cg-RX-API-DMAC7.html) |
| DK (1) | DK1959991T3 (cg-RX-API-DMAC7.html) |
| EC (1) | ECSP088531A (cg-RX-API-DMAC7.html) |
| ES (2) | ES2551604T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL191397A (cg-RX-API-DMAC7.html) |
| MA (1) | MA30252B1 (cg-RX-API-DMAC7.html) |
| MY (1) | MY181173A (cg-RX-API-DMAC7.html) |
| NO (1) | NO346055B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ568384A (cg-RX-API-DMAC7.html) |
| RU (2) | RU2440824C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG172617A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI537000B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007068411A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200804918B (cg-RX-API-DMAC7.html) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| RU2442793C2 (ru) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ |
| PL1976877T5 (pl) | 2005-11-30 | 2017-09-29 | Abbvie Inc | Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania |
| EP4793360A2 (en) | 2006-03-31 | 2026-08-19 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
| SG173409A1 (en) | 2006-11-24 | 2011-08-29 | Ac Immune Sa | N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| EP3127921A1 (en) | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| EP2106802A1 (en) | 2008-04-02 | 2009-10-07 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Modified peptides as synthetic vaccines in amyloid-associated disease |
| TW201920257A (zh) | 2008-04-11 | 2019-06-01 | 日商中外製藥股份有限公司 | 重複結合複數個抗原的抗原結合分子 |
| WO2010059253A2 (en) | 2008-11-24 | 2010-05-27 | Massachusets Institute Of Technology | Methods and compositions for localized agent delivery |
| MX2011009654A (es) * | 2009-03-18 | 2011-10-12 | Ac Immune Sa | Metodo para uso terapeutico. |
| UA107571C2 (xx) * | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| KR100929372B1 (ko) * | 2009-05-22 | 2009-12-02 | 고려대학교 산학협력단 | 아밀로이드 베타 단편을 유효성분으로 포함하는 돌연변이 sod1에 의한 als 예방 및 치료용 조성물 |
| AT508638B1 (de) * | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| EP2311823A1 (en) | 2009-10-15 | 2011-04-20 | AC Immune S.A. | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
| US20110229556A1 (en) * | 2010-03-19 | 2011-09-22 | Massachusetts Institute Of Technology | Lipid-coated polymer particles for immune stimulation |
| SG184127A1 (en) | 2010-03-19 | 2012-10-30 | Massachusetts Inst Technology | Lipid vesicle compositions and methods of use |
| US9149432B2 (en) | 2010-03-19 | 2015-10-06 | Massachusetts Institute Of Technology | Lipid vesicle compositions and methods of use |
| WO2011130377A2 (en) | 2010-04-15 | 2011-10-20 | Abbott Laboratories | Amyloid-beta binding proteins |
| ES2734552T3 (es) | 2010-04-16 | 2019-12-10 | Ac Immune Sa | Compuestos novedosos para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide |
| US20110256064A1 (en) | 2010-04-16 | 2011-10-20 | Ac Immune, S.A. | Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| EP2632434B1 (en) | 2010-10-26 | 2025-08-20 | AC Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| TWI654203B (zh) | 2010-11-30 | 2019-03-21 | Chugai Seiyaku Kabushiki Kaisha | 具有鈣依存性的抗原結合能力之抗體 |
| US20120148542A1 (en) | 2010-12-10 | 2012-06-14 | Lifeline Scientific, Inc. | Machine perfusion with complement inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
| CA2811188C (en) * | 2011-09-23 | 2020-04-28 | Andrea Pfeifer | Vaccine therapy |
| CA2869438C (en) | 2012-04-05 | 2021-08-17 | Ac Immune S.A. | Humanized tau antibody |
| MX374811B (es) | 2013-03-15 | 2025-03-06 | Ac Immune Sa | Anticuerpos anti-tau y métodos de uso. |
| CA3191031A1 (en) | 2013-09-27 | 2015-04-02 | Massachusetts Institute Of Technology | Carrier-free biologically-active protein nanostructures |
| US10654807B2 (en) * | 2013-12-20 | 2020-05-19 | The University Of Kansas | Toll-like receptor 8 agonists |
| MX2017005774A (es) | 2014-12-19 | 2017-07-28 | Chugai Pharmaceutical Co Ltd | Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso. |
| EA201791366A1 (ru) * | 2014-12-19 | 2018-02-28 | Чугаи Сейяку Кабусики Кайся | Антитела к c5 и способы их применения |
| CN114773469B (zh) | 2015-02-05 | 2025-12-19 | 中外制药株式会社 | 包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il-8-结合抗体及其应用 |
| IL301919A (en) * | 2015-03-27 | 2023-06-01 | Immatics Biotechnologies Gmbh | Innovative peptides and a combination of peptides for use in immunotherapy against various tumors |
| AU2016305087B2 (en) | 2015-08-12 | 2022-01-20 | Massachusetts Institute Of Technology | Cell surface coupling of nanoparticles |
| CN109715196A (zh) | 2016-06-13 | 2019-05-03 | 转矩医疗股份有限公司 | 用于促进免疫细胞功能的组合物和方法 |
| CN116271014A (zh) | 2016-08-05 | 2023-06-23 | 中外制药株式会社 | 用于预防或治疗il-8相关疾病的组合物 |
| WO2018081085A1 (en) * | 2016-10-25 | 2018-05-03 | The Regents Of The University Of California | Methods of diagnosis and treatment of alzheimer's disease |
| WO2018204302A1 (en) | 2017-05-01 | 2018-11-08 | Vanderbilt University | Phosphorylated hexaacyl disaccharides (phads) for treating or preventing infections |
| CA3074826A1 (en) | 2017-09-05 | 2019-03-14 | Torque Therapeutics, Inc. | Therapeutic protein compositions and methods of making and using the same |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| TW202333768A (zh) | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| CN108037277A (zh) * | 2017-12-07 | 2018-05-15 | 中国兽医药品监察所 | 一种区分牛布鲁氏菌疫苗免疫与自然感染状态的方法 |
| MA52180A (fr) * | 2018-04-10 | 2021-02-17 | Ac Immune Sa | Vaccins thérapeutiques anti-abêta |
| CN112165956A (zh) * | 2018-04-10 | 2021-01-01 | Ac免疫有限公司 | 抗Aβ治疗性疫苗 |
| CA3118692A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| SG11202108312PA (en) | 2019-02-08 | 2021-08-30 | Ac Immune Sa | Method of safe administration of phosphorylated tau peptide vaccine |
| MX2021012994A (es) | 2019-04-24 | 2022-03-04 | Janssen Pharmaceuticals Inc | Administracion heterologa de vacunas tau. |
| CN113853214A (zh) * | 2019-05-21 | 2021-12-28 | Ac免疫有限公司 | 抗Aβ疫苗治疗 |
| WO2021207303A1 (en) * | 2020-04-07 | 2021-10-14 | Alsatech, Inc. | Immune stimulation against coronavirus infections |
| WO2024156912A1 (en) | 2023-01-26 | 2024-08-02 | Ac Immune Sa | Anti-abeta vaccine therapy |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
| WO2025196262A1 (en) | 2024-03-22 | 2025-09-25 | Ac Immune Sa | Immunoassay involving antibodies binding vaccine adjuvants |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847082A (en) | 1987-01-21 | 1989-07-11 | Robert Sabin | Method of treatment of Alzheimer's disease using phytic acid |
| US5262332A (en) * | 1989-04-05 | 1993-11-16 | Brigham And Women's Hospital | Diagnostic method for Alzheimer's disease: examination of non-neural tissue |
| US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| HK1049279A1 (zh) * | 1999-11-29 | 2003-05-09 | Neurochem (International) Limited | 预防及治疗阿尔茨海默病(早老性痴呆)及淀粉样蛋白有关的病之疫苗 |
| DE10003992A1 (de) * | 2000-01-29 | 2001-08-09 | Bosch Gmbh Robert | Sensoranordnung |
| WO2002021141A2 (en) * | 2000-09-06 | 2002-03-14 | Aventis Pharma S.A. | Methods and compositions for diseases associated with amyloidosis |
| EP1203614A1 (de) | 2000-11-03 | 2002-05-08 | Polymun Scientific Immunbiologische Forschung GmbH | Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln |
| US6906169B2 (en) * | 2001-05-25 | 2005-06-14 | United Biomedical, Inc. | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| WO2003092700A1 (en) * | 2002-04-29 | 2003-11-13 | Gmp Oxycell, Inc. | Inositol pyrophosphates, and methods of use thereof |
| KR20050101537A (ko) | 2002-12-24 | 2005-10-24 | 뉴로켐 (인터내셔널) 리미티드 | 베타-아밀로이드 관련 질환의 치료를 위한 치료 제제 |
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US7884188B2 (en) * | 2003-06-02 | 2011-02-08 | Varleigh Immuno Pharmaceuticals (Vip) Ltd | Complement inhibitors |
| WO2005012330A2 (en) * | 2003-07-30 | 2005-02-10 | Brigham And Women's Hospital, Inc. | AMYLOID β-PEPTIDE AND METHODS OF USE |
| US20060257396A1 (en) * | 2004-12-15 | 2006-11-16 | Jacobsen Jack S | Abeta antibodies for use in improving cognition |
| EP1676859A1 (en) * | 2004-12-30 | 2006-07-05 | Pevion Biotech Ltd. | Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| NZ568012A (en) * | 2005-12-12 | 2012-07-27 | Ac Immune Sa | A beta 1-42 specific monoclonal antibodies with therapeutic properties |
-
2006
- 2006-12-08 CA CA2633399A patent/CA2633399C/en active Active
- 2006-12-08 AU AU2006326283A patent/AU2006326283B2/en not_active Ceased
- 2006-12-08 JP JP2008544833A patent/JP5249043B2/ja active Active
- 2006-12-08 CN CN200680046697.XA patent/CN101330923B/zh active Active
- 2006-12-08 MY MYPI20081951A patent/MY181173A/en unknown
- 2006-12-08 NZ NZ568384A patent/NZ568384A/en unknown
- 2006-12-08 EP EP11172818.4A patent/EP2380588B1/en active Active
- 2006-12-08 KR KR1020087017128A patent/KR101152557B1/ko active Active
- 2006-12-08 EP EP06829455A patent/EP1959991B1/en active Active
- 2006-12-08 WO PCT/EP2006/011861 patent/WO2007068411A2/en not_active Ceased
- 2006-12-08 ES ES11172818.4T patent/ES2551604T3/es active Active
- 2006-12-08 BR BRPI0619747A patent/BRPI0619747B8/pt active IP Right Grant
- 2006-12-08 DK DK06829455.2T patent/DK1959991T3/da active
- 2006-12-08 RU RU2008128133/15A patent/RU2440824C2/ru active
- 2006-12-08 KR KR1020127002472A patent/KR101236611B1/ko active Active
- 2006-12-08 NO NO20082216A patent/NO346055B1/no unknown
- 2006-12-08 SG SG2011036969A patent/SG172617A1/en unknown
- 2006-12-08 ES ES06829455T patent/ES2407429T3/es active Active
- 2006-12-12 TW TW095146547A patent/TWI537000B/zh active
- 2006-12-12 US US11/637,607 patent/US7807175B2/en active Active
- 2006-12-12 AR ARP060105476A patent/AR058327A1/es not_active Application Discontinuation
-
2008
- 2008-05-13 IL IL191397A patent/IL191397A/en active IP Right Grant
- 2008-05-20 CR CR9994A patent/CR9994A/es not_active Application Discontinuation
- 2008-06-05 ZA ZA2008/04918A patent/ZA200804918B/en unknown
- 2008-06-12 EC EC2008008531A patent/ECSP088531A/es unknown
- 2008-07-11 MA MA31115A patent/MA30252B1/fr unknown
-
2009
- 2009-04-14 US US12/386,140 patent/US8603487B2/en active Active
-
2011
- 2011-10-12 RU RU2011141308/15A patent/RU2011141308A/ru not_active Application Discontinuation
-
2013
- 2013-02-13 JP JP2013025108A patent/JP2013126993A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008128133A (ru) | Терапевтическая вакцина | |
| CN101420983B (zh) | 包含超分子抗原构建体的组合物和方法 | |
| KR20110030554A (ko) | 항아밀로이드 면역원성 조성물, 방법 및 용도 | |
| EP2659908A1 (en) | Compositions | |
| US20060147417A1 (en) | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use | |
| US20120171239A1 (en) | Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use | |
| JPH05506234A (ja) | ワクチン組成物 | |
| WO1996010423A1 (en) | COMPOSITIONS CONTAINING A p53 DERIVED PROTEIN OR PEPTIDE, AN ADJUVANT, AND INTERLEUKIN-12 AND USES THEREOF | |
| DK2465533T3 (en) | Methods and compositions comprising supramolecular constructs | |
| JP2007527870A5 (cg-RX-API-DMAC7.html) | ||
| HK1172260B (en) | Methods and compositions comprising supramolecular constructs | |
| HK1130698B (en) | Methods and compositions comprising supramolecular constructs |